[Kinetics of Pseudomonas aeruginosa virulence gene expression during chronic lung infection in the murine model]

M Pierre1, R Le Berre, H Tiesset

  • 1EA 3925, unité de gastroentérologie, hépatologie et nutrition, laboratoire de bactériologie-hygiène, centre de biologie-pathologie, clinique de pédiatrie, hôpital Jeanne-de-Flandre, CHRU de Lille, 59037 Lille, France.

Abstract

Insights

Pseudomonas aeruginosa pulmonary infections show a decrease in type III secretion system genes and a rise in alginate production genes over seven days. This shift reflects changes seen in cystic fibrosis patients.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Pseudomonas aeruginosa is a Gram-negative bacterium causing significant human diseases.
  • It produces numerous virulence factors regulated by complex gene systems.
  • The interplay of these regulatory systems during lung infections remains unclear.

Purpose of the Study:

  • To investigate the expression dynamics of P. aeruginosa virulence genes (exoS, lasI, algD) during early chronic lung infection.
  • To correlate gene expression changes with known clinical observations in P. aeruginosa infections.

Main Methods:

  • Mice were infected intratracheally with P. aeruginosa embedded in agarose beads.
  • Expression levels of exoS, lasI, and algD genes were monitored over seven days.

Main Results:

  • A progressive decrease in exoS (Type III secretion system) gene transcription was observed.
  • Concurrently, lasI and algD (involved in quorum sensing and alginate production) gene transcription increased.
  • These findings align with clinical observations of reduced Type III secretion and increased mucoidy in cystic fibrosis patients.

Conclusions:

  • Chronic P. aeruginosa lung infection involves a regulatory shift.
  • This shift is characterized by decreased expression of Type III secretion system genes.
  • It is also marked by increased expression of genes related to alginate production, contributing to the mucoid phenotype.